Cite
HARVARD Citation
Sunakawa, Y. et al. (2016). Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer. Cancer biology & therapy. 17 (7), pp. 751-759. [Online].